Clinical significance of the HLA-E and CD94/NKG2 interaction (Q37907929)

25 August 2017

1 reference

title

Clinical significance of the HLA-E and CD94/NKG2 interaction (English)

1 reference

25 August 2017

Katarzyna Bogunia-Kubik

series ordinal

2

object named as

Katarzyna Bogunia-Kubik

1 reference

25 August 2017

Milena Iwaszko

1

1 reference

PubMed ID

21800130

25 August 2017

language of work or name

1 reference

29 July 2011

1 reference

Archivum Immunologiae et Therapiae Experimentalis

25 August 2017

1 reference

25 August 2017

59

1 reference

25 August 2017

5

1 reference

25 August 2017

353-367

1 reference

https://scigraph.springernature.com/pub.10.1007/s00005-011-0137-y

25 August 2017

0 references

cites work

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Structure of CD94 Reveals a Novel C-Type Lectin Fold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Clinical significance of HLA-E*0103 homozygosity on survival after allogeneic hematopoietic stem-cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

NKG2D gene polymorphism has a significant impact on transplant outcomes after HLA-fully-matched unrelated bone marrow transplantation for standard risk hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Classical and non-classical HLA molecules and p16(INK4a) expression in precursors lesions and invasive cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Definitive high resolution typing of HLA-E allelic polymorphisms: Identifying potential errors in existing allele data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E polymorphism in patients with nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Association of an NKG2D gene variant with systemic lupus erythematosus in two populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Expression of immune-modulatory molecules HLA-G and HLA-E by tumor cells in glioblastomas: an unexpected prognostic significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Association of DAP12 with activating CD94/NKG2C NK cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Intramembrane proteolysis of signal peptides: an essential step in the generation of HLA-E epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Human CD94 Gene Expression: Dual Promoters Differing in Responsiveness to IL-2 or IL-15

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

The human CD94 gene encodes multiple, expressible transcripts including a new partner of NKG2A/B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Natural killer cell activation and inhibition by receptors for MHC class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Association of HLA-E polymorphism with the outcome of hematopoietic stem-cell transplantation with unrelated donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA class I specific inhibitory receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: susceptibility for rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Cloning of NKG2-F, a new member of the NKG2 family of human natural killer cell receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Structure of the human CD94 C-type lectin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Antigen presentation by major histocompatibility complex class I-B molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E polymorphism in patients with recurrent spontaneous abortion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Homozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E and immunobiology of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Human uterine leukocytes and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Cutting edge: HLA-E binds a peptide derived from the ATP-binding cassette transporter multidrug resistance-associated protein 7 and inhibits NK cell-mediated lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

An activating immunoreceptor complex formed by NKG2D and DAP10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Linkage of the NKG2 and CD94 receptor genes to D12S77 in the human natural killer gene complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00005-011-0137-Y

10.1007/S00005-011-0137-Y

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21800130